Dr Martin Juneau, M.D., FRCP
Cardiologue, directeur de l'Observatoire de la prévention de l'Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention Watch, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.
Chile, an example of aggressive state intervention to combat the obesity epidemic
In response to the skyrocketing rate of obesity in the Chilean population, the authorities have imposed a law that severely regulates the promotion and sale of ultra-processed industrial products, especially among young people.
Plant-based meat substitutes reduce certain cardiovascular risk factors
Replacing meat with plant-based meat substitutes significantly decreases certain cardiovascular risk factors according to a randomized, controlled study conducted at Stanford University.
Smoking continues to decline among young people
The increase in vaping observed in recent years in Canada is associated with a significant decrease in smoking among young people.
The social environment, essential for mental and physical health
The level of social integration is one of the main predictors of individuals’ health status and life expectancy.
The cardiovascular benefits of soy
A large study (over 200,000 participants) reports that regular soy consumption is associated with a lower risk of coronary heart disease.
To prevent cardiovascular disease, medication should not be a substitute for improved lifestyle
Adopting a healthy lifestyle reduces the risk of cardiovascular disease by 80%, a much better protection than that offered by medication.
COVID-19 is a disease that also affects blood vessels
Patients who develop severe complications from COVID-19 often have bleeding disorders leading to abnormal blood clot formation.
Hydroxychloroquine and COVID-19: A potentially harmful effect on the heart
The results obtained for the treatment of patients with COVID-19 with hydroxychloroquine do not support its use in the current context. This treatment increases the corrected QT interval on the electrocardiogram, a recognized marker of an increased risk of fatal arrhythmias.
Obesity and heart function
A study sheds light on a mechanism of adaptation for the decrease in cardiac energy capacity induced by obesity.
COVID-19 and cardiovascular disease
In addition to being an important risk factor for COVID-19, studies indicate that cardiovascular disease may also be a consequence of SARS-CoV-2 coronavirus infection and that these cardiac conditions contribute to the mortality caused by severe forms of the disease.